Breaking News on Pharmaceutical Technology

Headlines > Processing & QC

EPA proposes fine for API plant over waste allegations

12-Oct-2011 - The US EPA plans to fine API manufacturer Rhode Technologies for alleged hazardous waste failings at its plant.

FDA releases final guidance on anti-counterfeiting excipients

12-Oct-2011 - The FDA has published final guidance on the use of excipients as anti-counterfeiting tools in solid oral dosage forms.

USP teams with Russian regulators to fight substandard drugs and raise quality standards

11-Oct-2011 - The United States Pharmacopeial Convention (USP) has forged closer ties with Russian regulators to help tackle substandard pharmaceuticals and harmonize quality standards.

Biologics growth prompts IMB cold-chain distribution guidance

11-Oct-2011 - The Irish Medicines Board (IMB) has published guidance for cold-chain storage and transport of APIs and finished products.

News in brief

ProteinSimple adds tech to cut sample analysis times

10-Oct-2011 - ProteinSimple has introduced a protein therapeutic quality control monitoring system to cut sample analysis times.

Influenza pandemic prompts EMA vaccine quality rethink

04-Oct-2011 - The EMA is developing new vaccine quality guidelines in response to shortcomings seen during the influenza pandemic.

Inspection data to be opened up in FDA transparency plan

04-Oct-2011 - The US FDA may add product and violation-specific searches to its publicly available database of inspections as part of a transparency push.

TGA proposes adopting 15 EMA guideline documents

03-Oct-2011 - The Australian TGA is considering adopting EMA guidance on residual solvents, genotoxic impurities and other GMP topics.

FDA takes GMP action against US & Chinese drugmakers

29-Sep-2011 - The US FDA has filed a permanent injunction against a US drugmaker and sent a warning letter to a Chinese API producer following cGMP problems.

Ukraine votes to criminalise drug counterfeiting

26-Sep-2011 - Ukraine's parliament, the Verkhovna Rada, has voted unanimously in favour of new legislation which will criminalise the production and trafficking of counterfeit drugs.

ProMetic supplying adsorbent to Chinese biosimilar biz

26-Sep-2011 - ProMetic Life Sciences is supplying an affinity adsorbent to a Chinese biopharm for use in scale-up of a biosimilar.

Crystallisation modelling can improve scale up, PSE says

26-Sep-2011 - Process Systems Enterprise (PSE) has developed crystallisation modelling software to improve throughput and simplify scale-up.

PerkinElmer's new service aims to speed up instrumentation qualification

22-Sep-2011 - PerkinElmer has launched its new Universal Operational Qualification (UOQ) service for pharmaceutical labs.

FDA hits Indian API plant with warning letter & import alert

22-Sep-2011 - The FDA has issued a warning letter and import alert to an Indian API manufacturer after finding major cGMP failings.

Pfizer invests $200m in conjugation, pegylation and QC at Ireland plant

21-Sep-2011 - Pfizer says investment in Irish manufacturing facility will boost vaccine conjugation and pegylation capacity and establish a new QC testing hub.

Pharma discharge checks called for to protect waterways

20-Sep-2011 - Researchers have called for closer monitoring of pharma manufacturing discharges after detecting endocrine disruption in fish downstream from a Sanofi plant.

GE Healthcare to invest in biomanufacturing tech

19-Sep-2011 - GE Healthcare will expand its range of biomanufacturing technologies under a new oncology-focused investment project.

Pall ends 2011 on a high as biopharm growth continues

15-Sep-2011 - Pall continued the trend seen throughout 2011 by posting double-digit sales growth at its biopharm unit in the fourth quarter.

FDA asks for powers to stop another heparin-like crisis

15-Sep-2011 - The FDA needs additional powers to update its “antiquated, domestically-focused statute” and end the “competitive advantage of non-compliance”, an agency official said.

Lonza MA plant sent FDA GMP warning letter about Eisai API

14-Sep-2011 - The FDA has sent a warning letter to Lonza’s Hopkinton, MA plant after inspectors found faults with how it produces an oncology API for Eisai.

News in brief

Dosage form monographs next in USP update drive

14-Sep-2011 - The USP is to revise over-the-counter (OTC) dosage form monographs as part of its modernisation collaboration with the FDA.

SSB and GE sign patent licensing deal for biomanufacturing techs

13-Sep-2011 - Sartorius Stedium Biotech (SSB) and GE Healthcare Life Sciences say new cross licensing deal will aid development of their respective biomanufacturing tech offerings.

US to Puerto Rico knowledge transfer cause of quality problems, study

08-Sep-2011 - Difficulties transferring know-how from US Pharmas to plants in Puerto Rico may be responsible for the high incidence of manufacturing quality problems on the island, according to the authors of a new study.

Cellcura signs HSA-free media deal with IDT for vacc development

07-Sep-2011 - CellCura has inked an agreement with IDT Biologika for the testing and adaptation of its protein-free (PF) media for the production of cell lines for vaccine manufacturing.

Roche launches biomanufacturing monitoring tech

06-Sep-2011 - Roche has launched a new analysis platform designed to help bio manufacturers monitor and optimise production operations.

Sign up for your free newsletter

Supplier Webinars